STOCK TITAN
  1. Home
  2. Sec-filings
  3. BDX
  4. [144] Becton, Dickinson and Co. SEC Filing

[144] Becton, Dickinson and Co. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock BDX logo
Becton Dickinson & Co

NYSE:BDX

BDX Rankings

#272 Ranked by Market Cap
#1308 Ranked by Dividends

BDX Latest News

Jul 14, 2025
Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing
Jul 7, 2025
BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment
May 28, 2025
BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease
May 27, 2025
BD to Present at Goldman Sachs 46th Annual Global Healthcare Conference
May 21, 2025
Cancer Patients Face Elevated Risk of Carrying Antimicrobial Resistant 'Superbugs'

BDX Latest SEC Filings

Jul 14, 2025
[8-K] Becton, Dickinson and Co. Reports Material Event
Jul 14, 2025
[8-K] Becton, Dickinson and Co. Reports Material Event
Jul 7, 2025
[Form 4] Becton, Dickinson and Co. Insider Trading Activity
Jul 7, 2025
[Form 3] Becton, Dickinson and Co. Initial Statement of Beneficial Ownership
Jul 7, 2025
[SCHEDULE 13G/A] Becton, Dickinson and Co. SEC Filing

BDX Stock Data

50.87B
284.95M
0.56%
93.73%
1.02%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
FRANKLIN LAKES